910O – Primary results of the phase III JAVELIN head & neck 100 trial: avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) - Cohen, E E; Ferris, R L; Psyrri, A (Ann Oncol, 2020)
et al.